HRP20031075B1 - Process for the preparation of racemic citalopram and/or s- or r-citalopram by separation of a mixture of r- and s-citalopram - Google Patents

Process for the preparation of racemic citalopram and/or s- or r-citalopram by separation of a mixture of r- and s-citalopram

Info

Publication number: HRP20031075B1
Authority: HR; Croatia
Prior art keywords: citalopram; acid salt; racemic; optionally; precipitate
Prior art date: 2001-06-25

Application number

HR20031075A

Other languages

English (en)

Croatian (hr)

Inventor

Eva Humble Rikke

Volsgaard Christensen Troels

Harold Rock Michael

Nielsen Ole

Petersen Hans

Dancer Robert

Original Assignee

H. Lundbeck A/S

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-06-25

Filing date

2002-06-25

Publication date

2011-12-31

2002-06-25 Application filed by H. Lundbeck A/S filed Critical H. Lundbeck A/S

2004-04-30 Publication of HRP20031075A2 publication Critical patent/HRP20031075A2/hr

2011-12-31 Publication of HRP20031075B1 publication Critical patent/HRP20031075B1/xx

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Neurology (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pain & Pain Management (AREA)
Psychiatry (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

HR20031075A 2001-06-25 2002-06-25 Process for the preparation of racemic citalopram and/or s- or r-citalopram by separation of a mixture of r- and s-citalopram HRP20031075B1 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DKPA200100991		2001-06-25
PCT/DK2002/000426 WO2003000672A1 (en)	2001-06-25	2002-06-25	Process for the preparation of racemic citalopram and/or s- or r-citalopram by separation of a mixture of r- and s-citalopram

Publications (2)

Publication Number	Publication Date
HRP20031075A2 HRP20031075A2 (en)	2004-04-30
HRP20031075B1 true HRP20031075B1 (en)	2011-12-31

Family

ID=8160584

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
HR20031075A HRP20031075B1 (en)	2001-06-25	2002-06-25	Process for the preparation of racemic citalopram and/or s- or r-citalopram by separation of a mixture of r- and s-citalopram

Country Status (39)

Country	Link
US (1)	US7112686B2 (cs)
EP (1)	EP1412341B1 (cs)
JP (2)	JP4377219B2 (cs)
KR (4)	KR100939945B1 (cs)
CN (2)	CN101440079B (cs)
AR (2)	AR034612A1 (cs)
AT (1)	ATE284395T1 (cs)
BG (1)	BG66372B1 (cs)
BR (1)	BRPI0210574B8 (cs)
CA (2)	CA2450890C (cs)
CO (1)	CO5550420A2 (cs)
CZ (1)	CZ305034B6 (cs)
DE (1)	DE60202216T2 (cs)
DK (1)	DK1412341T3 (cs)
EA (1)	EA006446B1 (cs)
ES (1)	ES2233834T3 (cs)
HR (1)	HRP20031075B1 (cs)
HU (1)	HU228476B1 (cs)
IL (1)	IL159229A0 (cs)
IS (1)	IS2426B (cs)
JO (1)	JO2389B1 (cs)
MA (1)	MA26260A1 (cs)
ME (2)	ME00027B (cs)
MX (1)	MXPA03011770A (cs)
MY (1)	MY133471A (cs)
NO (2)	NO329873B1 (cs)
NZ (1)	NZ530104A (cs)
PE (1)	PE20030122A1 (cs)
PL (1)	PL366560A1 (cs)
PT (1)	PT1412341E (cs)
RS (1)	RS50673B (cs)
SI (1)	SI1412341T1 (cs)
SK (1)	SK287696B6 (cs)
TN (1)	TNSN02062A1 (cs)
TW (1)	TWI236473B (cs)
UA (1)	UA75147C2 (cs)
UY (2)	UY27356A1 (cs)
WO (1)	WO2003000672A1 (cs)
ZA (1)	ZA200309633B (cs)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AR040970A1 (es)	2002-08-12	2005-04-27	Lundbeck & Co As H	Metodo para la separacion de intermediarios que pueden ser utilizados para la preparacion de escitalopram
NZ540281A (en)	2002-12-23	2008-07-31	Lundbeck & Co As H	Escitalopram hydrobromide and a method for the preparation thereof
SI1581483T1 (sl) *	2002-12-23	2012-09-28	Lundbeck & Co As H	POSTOPEK ZA PRIPRAVO RACEMATNEGA CITALOPRAM DIOLA IN/ALI iS-/i ALI iR-/i CITALOPRAM DIOLOV IN UPORABA TAKIH DIOLOV ZA UÄŚINKOVINO RACEMATNEGA CITALOPRAMA, iR-/i CITALOPRAMA IN/ALI iS-/i CITALOPRAMA
JP4505335B2 (ja)	2002-12-23	2010-07-21	ハー・ルンドベック・アクチエゼルスカベット	ラセミ体シタロプラムジオール（ｒａｃｅｍｉｃｃｉｔａｌｏｐｒａｍｄｉｏｌ）および／またはＳ−もしくはＲ−シタロプラムジオールの製造方法、およびラセミ体シタロプラム、Ｒ−シタロプラムおよび／またはＳ−シタロプラムを製造するために、上記ジオールを使用する方法。
AU2003223105A1 (en) *	2003-03-24	2004-10-18	Hetero Drugs Limited	Novel crystalline forms of (s)-citalopram oxalate
CN100569765C (zh)	2003-12-19	2009-12-16	杭州民生药业集团有限公司	西酞普兰中间体晶体碱
TWI339651B (en) *	2004-02-12	2011-04-01	Lundbeck & Co As H	Method for the separation of intermediates which may be used for the preparation of escitalopram
NZ549100A (en) *	2004-03-05	2010-02-26	Lundbeck & Co As H	Crystalline composition containing escitalopram oxalate
US20050196453A1 (en)	2004-03-05	2005-09-08	H. Lundbeck A/S	Crystalline composition containing escitalopram
ITMI20040717A1 (it)	2004-04-09	2004-07-09	Adorkem Technology Spa	Procedimento chemo-enzimatico per la preparazione dell'escitalopram
JP2006008603A (ja) *	2004-06-25	2006-01-12	Sumitomo Chemical Co Ltd	光学活性シタロプラムの製造方法、その中間体およびその製造方法
KR101166280B1 (ko) *	2004-08-23	2013-11-27	썬 파마 글로벌 에프제트이	시탈로프램 및 에난티오머의 제조 방법
US7989645B2 (en) *	2004-08-23	2011-08-02	Sun Pharma Global Fze	Process for preparation of citalopram and enantiomers
US20110196032A1 (en) *	2005-05-20	2011-08-11	Ashish Gogia	Pharmaceutical Dosage Form of an Antidepressant
US7834201B2 (en)	2005-06-22	2010-11-16	H. Lundbeck A/S	Crystalline base of escitalopram and orodispersible tablets comprising escitalopram base
TWI358407B (en) *	2005-06-22	2012-02-21	Lundbeck & Co As H	Crystalline base of escitalopram and orodispersibl
KR20080080094A (ko)	2005-10-14	2008-09-02	하. 룬트벡 아크티에 셀스카브	에스시탈로프람 및 부프로피온의 저용량 조합물을 이용한중추신경계 장애의 치료 방법
WO2008059514A2 (en) *	2006-07-31	2008-05-22	Cadila Healthcare Limited	Process for preparing escitalopram
US8022232B2 (en)	2007-09-11	2011-09-20	H. Lundbeck A/S	Method for manufacture of escitalopram
FI121570B (fi)	2007-09-11	2011-01-14	Lundbeck & Co As H	Menetelmä essitalopraamin valmistamiseksi
CN100548974C (zh) *	2007-10-11	2009-10-14	浙江大学	西酞普兰中间体的萃取分离方法
CN101560199B (zh) *	2008-04-16	2013-09-18	北京德众万全药物技术开发有限公司	一种依地普仑的制备方法
TWI381813B (zh)	2010-01-12	2013-01-11	Taiwan Paiho Ltd	A Velcro assembly for a foamed article and a foamed article comprising the adhesive tape assembly

Citations (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0347066A1 (en) *	1988-06-14	1989-12-20	H. Lundbeck A/S	New enantiomers and their isolation

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB8419963D0 (en) *	1984-08-06	1984-09-12	Lundbeck & Co As H	Intermediate compound and method
HK1043129B (zh) *	1999-10-25	2004-10-21	H‧隆德贝克有限公司	西酞普蘭的製備方法

2002
- 2002-06-21 AR ARP020102350A patent/AR034612A1/es active IP Right Grant
- 2002-06-23 JO JO200265A patent/JO2389B1/en active
- 2002-06-24 PE PE2002000551A patent/PE20030122A1/es active IP Right Grant
- 2002-06-24 TN TNTNSN02062A patent/TNSN02062A1/en unknown
- 2002-06-25 CN CN2008102158851A patent/CN101440079B/zh not_active Expired - Lifetime
- 2002-06-25 RS YUP-1014/03A patent/RS50673B/sr unknown
- 2002-06-25 SI SI200230078T patent/SI1412341T1/xx unknown
- 2002-06-25 KR KR1020097004586A patent/KR100939945B1/ko not_active Expired - Lifetime
- 2002-06-25 TW TW091113845A patent/TWI236473B/zh not_active IP Right Cessation
- 2002-06-25 WO PCT/DK2002/000426 patent/WO2003000672A1/en not_active Ceased
- 2002-06-25 CA CA2450890A patent/CA2450890C/en not_active Expired - Fee Related
- 2002-06-25 ES ES02742848T patent/ES2233834T3/es not_active Expired - Lifetime
- 2002-06-25 PT PT02742848T patent/PT1412341E/pt unknown
- 2002-06-25 EA EA200400082A patent/EA006446B1/ru not_active IP Right Cessation
- 2002-06-25 JP JP2003507077A patent/JP4377219B2/ja not_active Expired - Lifetime
- 2002-06-25 ME MEP-2008-15A patent/ME00027B/me unknown
- 2002-06-25 KR KR1020107006751A patent/KR20100052550A/ko not_active Ceased
- 2002-06-25 HU HU0400293A patent/HU228476B1/hu unknown
- 2002-06-25 BR BRPI0210574A patent/BRPI0210574B8/pt not_active IP Right Cessation
- 2002-06-25 MY MYPI20022382A patent/MY133471A/en unknown
- 2002-06-25 CA CA2691149A patent/CA2691149C/en not_active Expired - Fee Related
- 2002-06-25 UA UA20031211986A patent/UA75147C2/uk unknown
- 2002-06-25 MA MA26713A patent/MA26260A1/fr unknown
- 2002-06-25 UY UY27356A patent/UY27356A1/es not_active IP Right Cessation
- 2002-06-25 SK SK51-2004A patent/SK287696B6/sk unknown
- 2002-06-25 IL IL15922902A patent/IL159229A0/xx active IP Right Grant
- 2002-06-25 KR KR1020037016853A patent/KR100902530B1/ko not_active Expired - Lifetime
- 2002-06-25 CN CNB028126688A patent/CN100429208C/zh not_active Expired - Lifetime
- 2002-06-25 US US10/482,000 patent/US7112686B2/en not_active Expired - Lifetime
- 2002-06-25 DK DK02742848T patent/DK1412341T3/da active
- 2002-06-25 PL PL02366560A patent/PL366560A1/xx not_active Application Discontinuation
- 2002-06-25 CZ CZ2004-131A patent/CZ305034B6/cs not_active IP Right Cessation
- 2002-06-25 EP EP02742848A patent/EP1412341B1/en not_active Expired - Lifetime
- 2002-06-25 KR KR1020087026708A patent/KR20080100498A/ko not_active Ceased
- 2002-06-25 AT AT02742848T patent/ATE284395T1/de active
- 2002-06-25 MX MXPA03011770A patent/MXPA03011770A/es active IP Right Grant
- 2002-06-25 DE DE60202216T patent/DE60202216T2/de not_active Expired - Lifetime
- 2002-06-25 NZ NZ530104A patent/NZ530104A/en not_active IP Right Cessation
- 2002-06-25 ME MEP-15/08A patent/MEP1508A/xx unknown
- 2002-06-25 HR HR20031075A patent/HRP20031075B1/xx not_active IP Right Cessation
2003
- 2003-12-08 IS IS7068A patent/IS2426B/is unknown
- 2003-12-11 ZA ZA2003/09633A patent/ZA200309633B/en unknown
- 2003-12-18 NO NO20035671A patent/NO329873B1/no not_active IP Right Cessation
2004
- 2004-01-14 BG BG108532A patent/BG66372B1/bg unknown
- 2004-01-22 CO CO04004620A patent/CO5550420A2/es not_active Application Discontinuation
2009
- 2009-04-17 JP JP2009101188A patent/JP5064436B2/ja not_active Expired - Lifetime
2010
- 2010-10-13 NO NO20101420A patent/NO335106B1/no not_active IP Right Cessation
2011
- 2011-10-19 AR ARP110103869A patent/AR083483A2/es active IP Right Grant
2014
- 2014-11-21 UY UY0001035850A patent/UY35850A/es not_active IP Right Cessation

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0347066A1 (en) *	1988-06-14	1989-12-20	H. Lundbeck A/S	New enantiomers and their isolation

Also Published As

Publication number	Publication date
KR20080100498A (ko)	2008-11-18
NO329873B1 (no)	2011-01-17
KR100902530B1 (ko)	2009-06-15
NO335106B1 (no)	2014-09-15
HK1068627A1 (zh)	2005-04-29
ZA200309633B (en)	2005-02-23
EA006446B1 (ru)	2005-12-29
CA2691149A1 (en)	2003-01-03
CN100429208C (zh)	2008-10-29
SK512004A3 (en)	2004-05-04
CN1520405A (zh)	2004-08-11
HU228476B1 (en)	2013-03-28
NO20035671D0 (no)	2003-12-18
BRPI0210574B8 (pt)	2021-05-25
BR0210574A (pt)	2004-08-03
CZ2004131A3 (cs)	2004-04-14
CA2691149C (en)	2011-09-13
NZ530104A (en)	2006-08-31
TNSN02062A1 (en)	2005-12-23
EP1412341A1 (en)	2004-04-28
CA2450890C (en)	2011-02-15
JO2389B1 (en)	2007-06-17
KR100939945B1 (ko)	2010-02-04
SK287696B6 (sk)	2011-06-06
PT1412341E (pt)	2005-04-29
DK1412341T3 (da)	2005-04-04
UY35850A (es)	2016-06-30
MA26260A1 (fr)	2004-09-01
ME00027B (me)	2010-02-10
HUP0400293A2 (hu)	2004-09-28
MY133471A (en)	2007-11-30
RS50673B (sr)	2010-06-30
EP1412341B1 (en)	2004-12-08
JP2009203233A (ja)	2009-09-10
KR20040030702A (ko)	2004-04-09
ATE284395T1 (de)	2004-12-15
IS2426B (is)	2008-10-15
HUP0400293A3 (en)	2007-05-29
AU2002344948B2 (en)	2007-08-16
CO5550420A2 (es)	2005-08-31
AR034612A1 (es)	2004-03-03
RS101403A (sr)	2007-02-05
SI1412341T1 (en)	2005-04-30
UA75147C2 (en)	2006-03-15
MXPA03011770A (es)	2004-04-02
CZ305034B6 (cs)	2015-04-08
JP5064436B2 (ja)	2012-10-31
UY27356A1 (es)	2003-01-31
NO20035671L (no)	2003-12-18
IL159229A0 (en)	2004-06-01
US7112686B2 (en)	2006-09-26
DE60202216D1 (de)	2005-01-13
PE20030122A1 (es)	2003-02-12
CN101440079A (zh)	2009-05-27
CN101440079B (zh)	2011-05-25
JP4377219B2 (ja)	2009-12-02
HK1132729A1 (en)	2010-03-05
PL366560A1 (en)	2005-02-07
KR20100052550A (ko)	2010-05-19
TWI236473B (en)	2005-07-21
NO20101420L (no)	2003-12-18
BR0210574B1 (pt)	2014-03-04
HRP20031075A2 (en)	2004-04-30
ES2233834T3 (es)	2005-06-16
KR20090031958A (ko)	2009-03-30
CA2450890A1 (en)	2003-01-03
BG66372B1 (bg)	2013-10-31
WO2003000672A1 (en)	2003-01-03
EA200400082A1 (ru)	2004-06-24
MEP1508A (xx)	2010-02-10
JP2004536093A (ja)	2004-12-02
AR083483A2 (es)	2013-02-27
BG108532A (bg)	2005-04-30
US20040259940A1 (en)	2004-12-23
IS7068A (is)	2003-12-08
DE60202216T2 (de)	2005-12-08

Legal Events

Date	Code	Title	Description
2004-04-30	A1OB	Publication of a patent application
2005-01-28	ARAI	Request for the grant of a patent on the basis of the submitted results of a substantive examination of a patent application
2005-01-28	RESP	Petition for restitutio in integrum
2005-02-09	RESU	Restitutio in integrum adopted
2011-12-31	B1PR	Patent granted
2019-05-17	ODRP	Renewal fee for the maintenance of a patent	Payment date: 20190506 Year of fee payment: 18
2020-06-26	ODRP	Renewal fee for the maintenance of a patent	Payment date: 20200603 Year of fee payment: 19
2021-08-06	ODRP	Renewal fee for the maintenance of a patent	Payment date: 20210624 Year of fee payment: 20
2022-06-29	PB20	Patent expired after termination of 20 years	Effective date: 20220625

Publication	Publication Date	Title
TNSN02062A1 (en)	2005-12-23	Process for the preparation of racemic citalopram and/or s- or r -citalopram by separation of a mixture of r- and s-citalopram
SE0103046L (sv)	2001-11-14	Kristallin bas av citalopram
JP2004536093A5 (ja)	2006-01-05	Ｒ−及びｓ−シタロプラムの混合物を分離することによってラセミシタロプラム及びｓ−もしくはｒ−シタロプラムを製造する方法
EA200300703A1 (ru)	2003-12-25	Пищевая композиция, подходящая для поверхностного обжаривания, включающая лецитин подсолнечника
ATE349451T1 (de)	2007-01-15	Verfahren zur herstellung von clopidogrel
IS7886A (is)	2005-06-09	Aðferð við framleiðslu á rasemísku sítalópram díóli og/eða S- eða R- sítalópram díólum og notkun slíkra díóla við framleiðslu á rasemísku sítalóprami, R-sítalóprami og/eða S-sítalóprami
ATE316082T1 (de)	2006-02-15	Prozess zur herstellung von r(+)alpha-liponsäure
ATE515496T1 (de)	2011-07-15	Verfahren zur herstellung von enantiomerenangereicherter indolin-2-carbonsäure
DE60101786D1 (de)	2004-02-19	Verfahren zur herstellung von citalopram
ATE302749T1 (de)	2005-09-15	Verfahren zur herstellung von 5-aminosalicylsäure
TW200512202A (en)	2005-04-01	A process for the preparation of racemic citalopram diol and/or S- or R-citalopram diols and the use of such diols for the preparation of racemic citalopram, R-citalopram and/or S-citalopram
HRPK20070454B3 (en)	2010-04-30	A process for the preparation of racemic citalopram diol and/or s- or r- citalopram diols and the use of such diols for the preparation of racemic citalopram, r-citalopram and/or s-citalopram
WO2005012278A3 (en)	2005-06-16	Process for purifying citalopram using polybasic acids
ATE375355T1 (de)	2007-10-15	Verfahren zur herstellung von cefpodoxim-proxetil
ATE250581T1 (de)	2003-10-15	Verfahren zur herstellung von 3-cyanopyridin aus 2-methyl-1,5-pentandiamin
ATE255571T1 (de)	2003-12-15	Methode zur trennung von racemischen mischungen von 5-substituierten 4-hydroxy-2-furanonen
KR830004190A (ko)	1983-07-06	시클로프로판 카르복실산 에스테르 유도체의 제조방법
JPS52100474A (en)	1977-08-23	Production of 5-bromo-3-(2-pyridyl)indole derivative
DE60001226D1 (de)	2003-02-20	Neues verfahren zur herstellung von etoposid